Study: Rural cancer patients cross state lines for specialized care
In a federally funded study, researchers from Huntsman Cancer Institute at the University of Utah (the U) found that 7% of Medicare patients cross ...
Tag: Chemotherapy
Triple therapy reduces tumor burden and improves survival in glioblastoma models
A new research paper was published in Oncotarget, Volume 16, on March 27, 2025, titled "Imipridones ONC201/ONC206 + RT/TMZ triple (IRT) therapy ...
Study uncovers how resistance to chemotherapies may occur in some cancers
Investigators at Mass General Brigham have uncovered how resistance to chemotherapies may occur in some cancers. Researchers focused on a ...
Breast cancer survivors face accelerated aging tied to tumors and treatment
Many breast cancer (BC) survivors experience accelerated aging, potentially due to the cancer itself or the effects of various treatments. ...
Adding chemotherapy to radiotherapy does not improve outcomes for cervical cancer patients
Results from the NRG Oncology GOG-0263 phase III clinical trial testing the addition of cisplatin-based chemotherapy to adjuvant radiotherapy following ...
Unraveling the genetic differences between LUAD and LUSC in lung cancer
Lung cancer remains one of the leading causes of cancer-related mortality, with lung adenocarcinoma (LUAD) and lung squamous cell carcinoma ...
EZH2 inhibition offers hope for fighting treatment-resistant cancers
The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review ...
First-ever clinical trials evaluate fenofibrate as treatment for HPV-related cancers
A team from University Hospitals Seidman Cancer Center is launching the nation's first-ever clinical trials evaluating the cholesterol drug fenofibrate (Triglide, Fibricor, ...
AstraZeneca receives positive NICE recommendations for lung cancer treatment
AstraZeneca announced that this week it has received two positive recommendations from the National Institute for Health and Care Excellence ...
Disrupting the circadian rhythm of glioblastoma slows tumor growth, study says
Virtually every cell in the human body has an internal clock. These clocks take their cues from a central clock ...